Sanctura XR (Trospium Chloride) - Summary

SANCTURA XR SUMMARY

SANCTURA XR is an extended-release formulation of trospium chloride, a quaternary ammonium compound. Trospium chloride is an antispasmodic, antimuscarinic agent.

SANCTURA^® XR is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

See all Sanctura XR indications & dosage >>

SANCTURA XR NEWS HIGHLIGHTS

Published Studies Related to Sanctura XR (Trospium)

Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study. [2008.03]

Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial. [2007.09]

Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients? [2006.12]

Predictive power of an in vitro system to assess drug interactions of an antimuscarinic medication: a comparison of in vitro and in vivo drug-drug interaction studies of trospium chloride with digoxin. [2006.07]

Multicenter phase III trial studying trospium chloride in patients with overactive bladder. [2006.02]

more >>

Clinical Trials Related to Sanctura XR (Trospium)

InSite for Urinary Urge Incontinence [Recruiting]

InSite for Urinary Urgency-Frequency [Recruiting]

more >>